| Nome |
# |
|
Clinicians’ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, “Real-Life”, Case-Control Study, file e4233f18-7b1f-2860-e053-6605fe0a460a
|
502
|
|
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression, file 114fed17-b83b-46da-91ef-667cebee5d84
|
308
|
|
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting, file e4233f17-5bd2-2860-e053-6605fe0a460a
|
115
|
|
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage, file e4233f16-15f4-2860-e053-6605fe0a460a
|
84
|
|
null, file e4233f17-03df-2860-e053-6605fe0a460a
|
84
|
|
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling., file e4233f14-fc88-2860-e053-6605fe0a460a
|
64
|
|
Intratumoral delivery of immunotherapy - Act locally, think globally, file e4233f16-cd35-2860-e053-6605fe0a460a
|
64
|
|
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report, file e4233f17-787b-2860-e053-6605fe0a460a
|
46
|
|
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody., file e4233f16-3733-2860-e053-6605fe0a460a
|
29
|
|
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study, file af98305d-13fa-42b5-8bd6-2e3e7fe2bd8b
|
27
|
|
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes, file e4233f17-4b33-2860-e053-6605fe0a460a
|
26
|
|
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors, file e4233f18-50d2-2860-e053-6605fe0a460a
|
23
|
|
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells, file e4233f16-ec7e-2860-e053-6605fe0a460a
|
22
|
|
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable, file e4233f17-0908-2860-e053-6605fe0a460a
|
22
|
|
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer, file e4233f17-5d24-2860-e053-6605fe0a460a
|
22
|
|
Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma, file e4233f17-d007-2860-e053-6605fe0a460a
|
22
|
|
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer, file 750a3119-9409-45aa-b0c4-77c77b7408be
|
21
|
|
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials, file e4233f17-03db-2860-e053-6605fe0a460a
|
19
|
|
Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage? Reply to Kadri Altundag, file e4233f16-1dd0-2860-e053-6605fe0a460a
|
18
|
|
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives, file e4233f18-a038-2860-e053-6605fe0a460a
|
18
|
|
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer, file 153c376a-53d2-4c7a-bba3-266492c3026d
|
17
|
|
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study, file e4233f17-747f-2860-e053-6605fe0a460a
|
17
|
|
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation", file e4233f17-9200-2860-e053-6605fe0a460a
|
17
|
|
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study, file e4233f17-962b-2860-e053-6605fe0a460a
|
16
|
|
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates, file e4233f18-97d7-2860-e053-6605fe0a460a
|
16
|
|
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial, file e4233f19-6a66-2860-e053-6605fe0a460a
|
16
|
|
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study, file e4233f17-dab5-2860-e053-6605fe0a460a
|
15
|
|
Retroperitoneal extension of massive ulcerated testicular seminoma through the inguinal canal: A case report, file e4233f18-7ad2-2860-e053-6605fe0a460a
|
15
|
|
Exosomes as pleiotropic players in pancreatic cancer, file e4233f18-87d9-2860-e053-6605fe0a460a
|
15
|
|
Prognostic relevance of LGALS3BP in human colorectal carcinoma, file e4233f17-ee8a-2860-e053-6605fe0a460a
|
14
|
|
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy, file ab058d0f-f757-4277-902f-6758ff982512
|
13
|
|
null, file b071599e-6315-417a-8e51-cbf134730a05
|
13
|
|
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression, file e4233f18-940d-2860-e053-6605fe0a460a
|
13
|
|
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey, file e4233f15-caa2-2860-e053-6605fe0a460a
|
12
|
|
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial, file e4233f16-27ed-2860-e053-6605fe0a460a
|
12
|
|
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective, file e4233f17-ba93-2860-e053-6605fe0a460a
|
12
|
|
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: Current evidence and literature-based meta-analysis of randomized trials, file e4233f18-3daf-2860-e053-6605fe0a460a
|
12
|
|
A perspective analysis: microRNAs, glucose metabolism, and drug resistance in colon cancer stem cells, file e4233f18-79dd-2860-e053-6605fe0a460a
|
12
|
|
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study, file 3a4b6c7c-5bce-4ec1-8fd7-7ffb4638d71b
|
11
|
|
90K immunostimulatory glycoprotein in children with juvenile idiopathic arthritis, file ba96dcf5-8aac-49bc-80fa-6862004b2297
|
11
|
|
Deep polychromatic flow cytometry characterization of circulating endothelial cells in metastatic colorectal cancer patients, file e4233f18-978d-2860-e053-6605fe0a460a
|
10
|
|
The HSP90/R2TP assembly chaperone promotes cell proliferation in the intestinal epithelium, file e4233f18-cb27-2860-e053-6605fe0a460a
|
10
|
|
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer, file e671c42f-90e1-4bbe-9e73-05250e4c5bcb
|
10
|
|
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting, file eefa9c0c-0a62-48a3-b14b-64ceadad9992
|
10
|
|
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study, file cbf6c109-9e4b-4d70-a8a0-4fbf9b6c2a48
|
9
|
|
null, file e0d894a3-d993-4ea9-a20f-cdce6c8cf4bb
|
9
|
|
Fabric Phase Sorptive Extraction-High Performance Liquid Chromatography-Photo Diode Array Detection Method for Simultaneous Monitoring of Three Inflammatory Bowel Disease Treatment Drugs in Whole Blood, Plasma and Urine, file e4233f19-64e8-2860-e053-6605fe0a460a
|
9
|
|
Flow Cytometry Detection of Anthracycline-Treated Breast Cancer Cells: An Optimized Protocol, file 6761937a-d146-4f7e-aadb-2e381b9ec6bb
|
8
|
|
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting, file c5838e51-8b69-42be-b4e0-7c0567e424dd
|
8
|
|
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer, file e4233f15-0a20-2860-e053-6605fe0a460a
|
8
|
|
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: A systematic review, file e4233f15-babe-2860-e053-6605fe0a460a
|
8
|
|
Fabric Phase Sorptive Extraction-High Performance Liquid Chromatography-Photo Diode Array Detection Method for Simultaneous Monitoring of Three Inflammatory Bowel Disease Treatment Drugs in Whole Blood, Plasma and Urine, file e4233f16-aa29-2860-e053-6605fe0a460a
|
8
|
|
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial, file 0886a523-3310-467a-b37c-fcddef01c985
|
7
|
|
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting, file 26826aa7-b457-45c4-ad25-a9a93cb38bfd
|
7
|
|
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study, file 36207e4f-6d04-477b-93ad-5ed1b9859ba9
|
7
|
|
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo., file 5a50a26e-3c0b-49e6-872f-11fd81f9a2f3
|
7
|
|
Alectinib induced regression of renal and hepatic cysts caused by crizotinib, file 5e173c4c-077d-4a35-a612-8319748f2396
|
7
|
|
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody, file 47a7496c-5e19-4e93-9b87-ada3db679b24
|
6
|
|
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study, file e1ff7b2d-1860-468c-8836-4204ca7fdc7f
|
6
|
|
Outcomes of HER2-positive early breast cancer patients
in the pre-trastuzumab and trastuzumab eras: a real-world
multicenter observational analysis. The RETROHER study, file e4233f15-1297-2860-e053-6605fe0a460a
|
6
|
|
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer, file e4233f14-f164-2860-e053-6605fe0a460a
|
5
|
|
Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey, file e4233f15-3d95-2860-e053-6605fe0a460a
|
5
|
|
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer, file 2b4ff7e3-523a-48cc-81af-781e794797b9
|
4
|
|
Prognostic value of gender and primary tumor location in metastatic colon cancer, file df8f4303-0b81-4032-a91d-8f4e51621185
|
4
|
|
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial, file e4233f16-cc38-2860-e053-6605fe0a460a
|
4
|
|
Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed., file 30d507c3-c0e8-4db1-a4ac-2bc94b34988c
|
3
|
|
Strain- and sex-dependent circadian changes in abcc2 transporter expression: implications for irinotecan chronotolerance in mouse ileum., file 3c63aafc-58b3-4acc-9cce-e2cf6e3b353e
|
3
|
|
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients, file 4e505980-bd6e-40c3-ae5f-f7710eddfe0a
|
3
|
|
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors, file e4233f15-00ab-2860-e053-6605fe0a460a
|
3
|
|
New Targets for Therapy in Pancreatic Cancer, file e4233f15-00ac-2860-e053-6605fe0a460a
|
3
|
|
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience, file e4233f17-03d7-2860-e053-6605fe0a460a
|
3
|
|
Relations between strain and gender dependencies of irinotecan toxicity and UGT1A1, CES2 and TOP1 expressions in mice., file 48c9f32c-b00e-48ee-9e86-ae9fe385fb02
|
2
|
|
null, file 7aac849c-2fda-48fd-a316-da3cd16bf4c0
|
2
|
|
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability, file b86f2386-edf1-48f0-bea2-d31e64505ff8
|
2
|
|
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides., file e4233f14-edfc-2860-e053-6605fe0a460a
|
2
|
|
90K (Mac-2 BP) and galectins in tumor progression and metastasis., file e4233f14-ee19-2860-e053-6605fe0a460a
|
2
|
|
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study., file e4233f14-ee2a-2860-e053-6605fe0a460a
|
2
|
|
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer, file e4233f15-6e57-2860-e053-6605fe0a460a
|
2
|
|
ERBB3 BINDING ANTIBODY, file e4233f16-d5ab-2860-e053-6605fe0a460a
|
2
|
|
Novel inhibitors of pvhl-elongin c binding, file e4233f17-20b2-2860-e053-6605fe0a460a
|
2
|
|
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation, file e4233f17-6ad0-2860-e053-6605fe0a460a
|
2
|
|
Occupational allergy: is there a role for nanoparticles?, file e4233f18-a34c-2860-e053-6605fe0a460a
|
2
|
|
null, file e4233f18-bf77-2860-e053-6605fe0a460a
|
2
|
|
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion, file e4233f18-e990-2860-e053-6605fe0a460a
|
2
|
|
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer, file 45d64c2d-1c74-44c1-bf85-02f31e7eafbd
|
1
|
|
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence, file aa4e8d13-0b2d-4534-b9ec-e537bcea210e
|
1
|
|
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks, file bd10f8fa-7c56-45d4-abbd-18dbd334f4a0
|
1
|
|
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival, file e4233f14-edac-2860-e053-6605fe0a460a
|
1
|
|
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer, file e4233f14-f0fb-2860-e053-6605fe0a460a
|
1
|
|
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein., file e4233f14-f190-2860-e053-6605fe0a460a
|
1
|
|
Unknown primary tumors, file e4233f14-f862-2860-e053-6605fe0a460a
|
1
|
|
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice., file e4233f15-0176-2860-e053-6605fe0a460a
|
1
|
|
Tumor-derived microvesicles: The metastasomes., file e4233f15-079e-2860-e053-6605fe0a460a
|
1
|
|
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer, file e4233f15-1291-2860-e053-6605fe0a460a
|
1
|
|
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study, file e4233f17-6224-2860-e053-6605fe0a460a
|
1
|
| Totale |
2.052 |